1)
Eid A, Hawash M. Biological evaluation of Safrole
oil and Safrole oil Nanoemulgel
as antioxidant, antidiabetic, antibacterial, antifungal and anticancer. BMC Complement
Med Ther. 2021 May 29;21(1):159. 2. Bayda S, Adeel M, Tuccinardi T, Cordani M,
Rizzolio F. The History of Nanoscience and Nanotechnology: From Chemical-Physical
Applications to Nanomedicine. Molecules. 2019 Dec 27;25(1):112.
2)
Singh Y, Meher J, Raval
K, Khan F, Chaurasia M, Jain N, Chourasia M. Nanoemulsion: Concepts,
development and applications in drug delivery. J Control Release. 2017 Apr
28;252:28-49.
3)
Weissig V, Lizano C,
Torchilin V. Selective DNA release from DQAsome/DNA complexes at
mitochondria-like membranes. Drug Deliv. 2000 Jan-Mar;7(1):1-5.
4)
Beig A, Miller J, Lindley
D, Carr R, Zocharski P, Agbaria R, Dahan A. Head-To- Head Comparison of
Different Solubility-Enabling Formulations of Etoposide and Their Consequent
Solubility-Permeability Interplay. J Pharm Sci. 2015 Sep;104(9):2941-7.
5)
A.A. Gade Abhishek V,
K.S. Salunkhe, S.R. Chaudhari , Gadge P.B, Dighe G.S, Review on: Self
Micro-Emulsifying Drug Delivery System, Am. J. PharmTech Res. (2015) 50â66.
6)
Pham-The H, Garrigues T,
Bermejo M, González-Ãlvarez I, Monteagudo MC, Cabrera-Pérez MÃ. Provisional classification and in silico study of biopharmaceutical system based on caco-2
cell permeability and dose number. Mol Pharm. 2013 Jun 3;10(6):2445-61.
7)
Kesharwani P, Banerjee S, Padhye S, Sarkar FH, Iyer AK. Parenterally administrable nano-micelles of
3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Colloids Surf
B Biointerfaces. 2015 Aug 1;132:138-45.
8)
Jain A, Jain K,
Kesharwani P, Jain N, Low density lipoproteins mediated nanoplatforms for
cancer targeting, J. Nanoparticle Res. 15 (2013) 1888.
9)
Kesharwani P, Xie L, Banerjee S, Mao G, Padhye S,
Sarkar F, Iyer A. Hyaluronic
acid- conjugated polyamidoamine dendrimers for targeted delivery of 3,4- difluorobenzylidene curcumin to CD44
overexpressing pancreatic cancer cells. Colloids Surf B Biointerfaces. 2015 Dec
1;136:413-23.
10) Gorain B, Choudhury H, Biswas E, Barik A, Jaisankar P, Pal T. A novel approach for nanoemulsion components
screening and nanoemulsion assay of olmesartan medoxomil through a developed
and validated HPLC method, RSC Adv. 3 (2013) 10887-10893.
11) Gorain
B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal T. Nanoemulsion
strategy for olmesartan medoxomil improves oral absorption and extended
antihypertensive activity in hypertensive rats, Colloids Surfaces B
Biointerfaces. 115 (2014) 286â294.
12) Kaushal
A, Gupta P, Bansal A. Amorphous drug delivery systems: molecular aspects, design,
and performance. Crit Rev Ther Drug Carrier
Syst. 2004;21(3):133-93.
13) Kawakami
K, Pikal M. Calorimetric investigation of the structural relaxation of
amorphous materials: evaluating validity of the methodologies. J Pharm Sci.
2005 May;94(5):948-65.
14) Ghanghoria
R, Kesharwani P, Agashe H, Jain N. Transdermal delivery of
cyclodextrin-solubilized curcumin. Drug Deliv Transl Res. 2013 Jun;3(3):272-85.
15) Kothule K, Kesharwani P, Gidwani S, Gide P. Development and Characterization of Chitosan Nanoparticles and Improvement of
Oral Bioavailability of Poorly Water- Soluble Acyclovir, Res. J. Pharm.
Technol. 3 (2010) 1241â1245.
16) Gorain
B, Tekade M, Kesharwani P, Iyer AK, Kalia K, Tekade RK. The use of
nanoscaffolds and dendrimers in tissue engineering. Drug Discov Today. 2017 Apr;22(4):652-664.
17) Pouton
C. Lipid formulations for oral administration of drugs: non-emulsifying,
self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm
Sci. 2000 Oct;11 Suppl 2:S93-8.
18) Bali
V, Ali M, Ali J. Nanocarrier for the enhanced bioavailability of a
cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability
assessment. Int J Pharm. 2011 Jan 17;403(1-2):46-56.
19) Shafiq-un-Nabi
S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar R, Ali M.
Formulation development and optimization using nanoemulsion technique: a
technical note. AAPS PharmSciTech. 2007 Apr 6;8(2):Article 28.
20) Choudhury
H, Gorain B, Chatterjee B, Mandal U, Sengupta P, Tekade R. Pharmacokinetic and
Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical
and Nasal Route. Curr Pharm Des. 2017;23(17):2504-2531.
21) Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S. Oil based
nanocarrier for improved oral delivery
of silymarin: In vitro
and in vivo studies. Int J Pharm.
2011 Jul 15;413(1-2):245-53.
22) Mansuri S, Kesharwani P, Tekade R, Jain N. Lyophilized mucoadhesive-dendrimer enclosed matrix
tablet for extended oral delivery of albendazole. Eur J Pharm Biopharm. 2016
May;102:202-13.
23) Shukla A, Mishra
V, Kesharwani P. Bilosomes in the context
of oral immunization: development, challenges and opportunities. Drug Discov Today. 2016 Jun;21(6):888-
24) 99. doi:
10.1016/j.drudis.2016.03.013. Epub 2016 Mar
30. PMID: 27038539.
25) Shafaat
K, Kumar B, Das S, Ul Hasan R, Prajapati S. Novel nanoemulsion as vehicles for
transdermal delivery of Clozapine: In vitro and in vivo studies. Int. J. Pharm.
Pharm. Sci. 5 (2013) 126â134.
26) Zhou
J, Zhou M, Yang F, Liu C, Le Pan R,
Chang Q. Involvement of the inhibition of intestinal glucuronidation in
enhancing the oral bioavailability of resveratrol by Labrasol containing nanoemulsions. Mol.
Pharm. 12 (2015) 1084â1095.
27) Kotta S, Khan A, Ansari S, Sharma R, Ali J. Anti HIV nanoemulsion formulation: Optimization and in vitro-in
vivo evaluation. Int. J. Pharm. 462 (2014) 129â134.
28) Iqbal
M, Md S, Sahni J, Baboota S.
Nanostructured lipid carriers system: recent advances in drug delivery. J.
Drug. (2012).
29) Kaur
J, Kaur J, Jaiswal S, Gupta G. RECENT ADVANCES IN TOPICAL DRUG DELIVERY SYSTEM. Pharm. Res. (2016).
30) Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. Skin permeation
mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J
31) Nanobiotechnology. 2008 Jul 9;6:8. 31. Huang X, Peng X, Wang Y, Wang Y,
Shin DM, El-Sayed MA, Nie S. A reexamination of active and passive tumor
targeting by using rod-shaped gold nanocrystals and covalently conjugated
peptide ligands. ACS Nano. 2010 Oct 26;4(10):5887-96.
32) 32. Delouise L. Applications of Nanotechnology in Dermatology. J.
Invest. Dermatol. 132 (2012) 964â975.
33. Gao F, Zhang
Z, Bu H, Huang Y, Gao Z, Shen J, Zhao C, Li
33) Y. Nanoemulsion improves the oral absorption
of candesartan cilexetil in rats: Performance and mechanism. J Control Release.
2011 Jan 20;149(2):168-74.
34) Khurana S, Bedi PM, Jain NK. Preparation and evaluation of solid
lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phys
Lipids. 2013 Oct-Nov;175-176:65-72.
35) Pund S, Pawar S, Gangurde S, Divate D. Transcutaneous delivery
of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical
characteristics, in vitro anti-psoriatic and anti-melanoma activity.
Int J Pharm. 2015 Jun 20;487(1-2):148-
56.
36) Sonneville-Aubrun O, Simonnet
JT, L'Alloret F. Nanoemulsions: a new vehicle
for skincare products. Adv Colloid Interface Sci. 2004 May
20;108-109:145-9.
37) Tadros T, Izquierdo P, Esquena J, Solans C. Formation and
stability of nano- emulsions. Adv Colloid Interface Sci. 2004 May
20;108-109:303-18.
38) Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma M. Nano-emulsions, Curr. Colloid. Interface Sci. 10 (2005)
102â110.
39) Formariz
T, Sarmento V, Silva-Junior A.
Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant
containing soya phosphatidylcholine, Colloids Surfaces B. (2006).
40) Gorain
B, Choudhury H, Tekade R, Karan S, Jaisankar P, Pal T. Comparative
biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral
nanoemulsion, Regul. Toxicol. Pharmacol. 82 (2016) 20â31.
41) Aparna
C, Srinivas P, Patnaik K. ENHANCED TRANSDERMAL PERMEABILITY OF TELMISARTAN BY A NOVEL NANOEMULSION GEL, IntJ. Pharm. Pharm.
Sci. 7 (2015) 335â342
42) Harwansh R, Mukherjee
P, Bahadur S, Biswas R. Enhanced permeability of ferulic acid
loaded nanoemulsion based gel through skin against UVA mediated oxidative
stress. Life Sci. 2015 Nov 15;141:202-11.
43) 42.Hussain A, Samad A, Singh S, Ahsan M, Haque M, Faruk A, Ahmed
F. Nanoemulsion gel-based topical delivery of an
antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv.
2016;23(2):642-47.
44) Mirza M, Ahmad S,
